Brief: Mangoceuticals Enters Into Marketing Agreement With Marius Pharmaceuticals
11/12/2023 22:25
Dec 11 (Reuters) - Mangoceuticals Inc MGRX.O :
* MANGOCEUTICALS INC - ON DECEMBER 10, ENTERED INTO A
MARKETING
AGREEMENT WITH MARIUS PHARMACEUTICALS
* MANGOCEUTICALS INC - AGREEMENT ALLOWING CO THE USE OF
TRADEMARK
"KYZATREX(REG)" ORAL TESTOSTERONE UNDECANOATE SOFTGEL CAPSULES
* MANGOCEUTICALS INC - AGREEMENT ALLOWING CO SELLING
KYZATREX(REG) ON THEIR WEBSITE
Further company coverage: MGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM